home / stock / adxs / adxs short
Short Information | Advaxis (NASDAQ:ADXS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 13,698,318 |
Total Actual Volume | 69,998,949 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 684,916 |
Average Short Percentage | 19.56% |
Is there a ADXS Short Squeeze or Breakout about to happen?
See the ADXS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
12-22-2021 | $0.29 | $0.24 | $0.2902 | $0.2356 | 11,640,473 | 1,546,604 | 13.29% |
12-21-2021 | $0.3033 | $0.2943 | $0.3033 | $0.287 | 3,165,617 | 680,882 | 21.51% |
12-20-2021 | $0.32 | $0.2962 | $0.32 | $0.2746 | 3,752,751 | 784,883 | 20.91% |
12-17-2021 | $0.3204 | $0.325 | $0.328 | $0.305 | 2,379,154 | 299,470 | 12.59% |
12-15-2021 | $0.3 | $0.3174 | $0.3245 | $0.293 | 1,714,019 | 458,576 | 26.75% |
12-14-2021 | $0.3126 | $0.309 | $0.3299 | $0.3 | 2,765,718 | 845,020 | 30.55% |
12-13-2021 | $0.3159 | $0.3126 | $0.33 | $0.3045 | 1,798,014 | 352,127 | 19.58% |
12-10-2021 | $0.3718 | $0.325 | $0.377 | $0.32 | 3,015,216 | 892,258 | 29.59% |
12-09-2021 | $0.3692 | $0.3478 | $0.382 | $0.347 | 2,360,508 | 360,425 | 15.27% |
12-08-2021 | $0.343 | $0.36 | $0.366 | $0.3398 | 1,672,367 | 88,699 | 5.3% |
12-07-2021 | $0.3538 | $0.3544 | $0.3799 | $0.35 | 2,844,696 | 207,966 | 7.31% |
12-06-2021 | $0.3134 | $0.3445 | $0.348 | $0.3013 | 2,738,762 | 456,561 | 16.67% |
12-01-2021 | $0.37 | $0.3444 | $0.3725 | $0.3302 | 3,256,281 | 796,957 | 24.47% |
11-30-2021 | $0.4 | $0.37 | $0.41 | $0.365 | 3,299,557 | 670,515 | 20.32% |
11-29-2021 | $0.3902 | $0.4002 | $0.42 | $0.3622 | 8,359,562 | 1,836,043 | 21.96% |
11-26-2021 | $0.3763 | $0.3847 | $0.3897 | $0.365 | 1,656,652 | 342,388 | 20.67% |
11-24-2021 | $0.3665 | $0.4017 | $0.4199 | $0.36 | 5,426,460 | 1,499,010 | 27.62% |
11-23-2021 | $0.3796 | $0.3621 | $0.3796 | $0.3501 | 1,868,892 | 293,011 | 15.68% |
11-22-2021 | $0.3807 | $0.368 | $0.3886 | $0.3508 | 3,302,961 | 613,494 | 18.57% |
11-19-2021 | $0.379 | $0.3772 | $0.3902 | $0.37 | 2,981,289 | 673,429 | 22.59% |
News, Short Squeeze, Breakout and More Instantly...
MONMOUTH JUNCTION, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced that it filed a Form 15 with the Securities and Exchange Commission (the “SEC”) to deregister its common stock under Section 12(g) ...
MONMOUTH JUNCTION, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced the completion of the previously announced sale of AL102, and related drug candidate AL101, to Immunome, Inc. (Nasdaq: IMNM). As per the ...
REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced that patient enrollment has been completed in the Phase 3 RINGSIDE study evaluating AL102 in desmoid tumors. A total of 156 ...